Legacy Meets Mindful Luxury at Hakone Sanctuary: Embrace Nature's Finest at Kinnotake Resorts with Black Friday Exclusive
HAKONE, Japan, Nov. 25, 2024 /PRNewswire/ -- Kinnotake Corporation has announced a Black Friday Sale for Kinnotake Resorts, granting exclusive access to three exceptional properties in Hakone, Kanagawa Prefecture. Each resort offers a distinctive...
Ascentage Pharma Appoints Ms. Marina S. Bozilenko and Dr. Debra Yu as Independent Non-Executive Directors
ROCKVILLE, Md. and SUZHOU, China, Nov. 25, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for...
SCG Cell Therapy Presents Promising Phase 1 Data for a Novel HBV-Specific TCR-T Therapy (SCG101) at the AASLD Liver Meeting 2024
SINGAPORE, Nov. 25, 2024 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company focused on developing innovative immunotherapies for infectious diseases and associated cancers, announced late-breaking data from its...
Corinex Ranked Number 331 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Attributes 352% Revenue Growth to expanded product offerings, successful strategic partnerships, and increased demand for grid flexibility solutions in international markets VANCOUVER, BC, Nov. 22, 2024 /PRNewswire/ -- Corinex today announced it...
At Its European Innovation Day 2024, Huawei Advocates Collaboration to Unlock Europe's Potential
PARIS, Nov. 22, 2024 /PRNewswire/ -- Huawei hosted the 2024 "Europe Innovation Day" in Paris, an event where European tech leaders, business representatives, and innovation experts explored opportunities for cross-border and cross-industry...
Akeso's Penpulimab Combination Therapy for First-line Treatment of Hepatocellular Carcinoma Accepted by NMPA
HONG KONG, Nov. 22, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted its supplemental new drug application (sNDA) for penpulimab, a...
Qudian Inc. Reports Third Quarter 2024 Unaudited Financial Results
XIAMEN, China, Nov. 22, 2024 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company in China, today announced its unaudited financial results for the quarter ended September 30, 2024. Third...
MINISO Announces Extraordinary General Meeting on January 17, 2025
GUANGZHOU, China, Nov. 22, 2024 /PRNewswire/ -- MINISO Group Holding Limited (NYSE: MNSO; HKEX: 9896) ("MINISO", "MINISO Group" or the "Company"), a global value retailer offering a variety of trendy lifestyle products featuring IP design, today...
Changes in Board and Committee Composition
SHANGHAI, Nov. 22, 2024 /PRNewswire/ -- Lufax Holding Ltd ("Lufax" or the "Company") (NYSE: LU and HKEX: 6623), a leading financial services enabler for small business owners in China, today announced that (i) Mr. Gregory Dean Gibb has retired from...
Bright Scholar Schedules Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2024 Ended August 31, 2024
CAMBRIDGE, England and FOSHAN, China, Nov. 22, 2024 /PRNewswire/ -- Bright Scholar Education Holdings Limited ("Bright Scholar," the "Company," "we" or "our") (NYSE: BEDU), a global premier education service company, today announced that it will...